Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|October 10, 2013
[Vitamin D and breast cancer: physiopathology, biological and clinical implications]Nelly Firmin, Pierre-Jean Lamy, Gilles Romieu, et al.
Cureus|June 28, 2023
A Case Report of SMARCA4-Deficient Thoracic Sarcoma: A Rare and Aggressive Disease With a Grim PrognosisSiham Lalaoui Rachidi, Nelly Firmin, Mohamed Elfadli, et al.
International Journal of Molecular Sciences|March 29, 2023
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the KeyQuentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi, et al.
Bulletin Du Cancer|September 6, 2024
[Borderlines and malignant phyllodes tumors of the breast: From the anatomopathological challenge to the standard of care]Mathias Neron, Aurélie Maran Gonzalez, Carmen Llacer, et al.
International Journal of Cancer|July 28, 2016
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
Cancer Management and Research|December 19, 2019
Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?Marie Alexandre, Aurélie Maran-Gonzalez, Marie Viala, et al.
BMC Cancer|July 9, 2016
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patientsAmélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
Nutrients|December 28, 2021
A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant ChemotherapyElodie Chartron, Nelly Firmin, Célia Touraine, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 7, 2023
Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamideThibaud Valentin, Marie Lambert, Léonor Chaltiel, et al.
Pageof 5